223 related articles for article (PubMed ID: 20013257)
21. Pharmacokinetics of linezolid in bone tissue investigated by in vivo microdialysis.
Stolle LB; Plock N; Joukhadar C; Arpi M; Emmertsen KJ; Buerger C; Riegels-Nielsen P; Kloft C
Scand J Infect Dis; 2008; 40(1):24-9. PubMed ID: 18097982
[TBL] [Abstract][Full Text] [Related]
22. Linezolid disposition after standard dosages in critically ill patients undergoing continuous venovenous hemofiltration: a report of 2 cases.
Pea F; Viale P; Lugano M; Pavan F; Scudeller L; Della Rocca G; Furlanut M
Am J Kidney Dis; 2004 Dec; 44(6):1097-102. PubMed ID: 15558532
[TBL] [Abstract][Full Text] [Related]
23. Impact of ontogeny on linezolid disposition in neonates and infants.
Kearns GL; Jungbluth GL; Abdel-Rahman SM; Hopkins NK; Welshman IR; Grzebyk RP; Bruss JB; Van Den Anker JN;
Clin Pharmacol Ther; 2003 Nov; 74(5):413-22. PubMed ID: 14586382
[TBL] [Abstract][Full Text] [Related]
24. Variability of linezolid concentrations after standard dosing in critically ill patients: a prospective observational study.
Zoller M; Maier B; Hornuss C; Neugebauer C; Döbbeler G; Nagel D; Holdt LM; Bruegel M; Weig T; Grabein B; Frey L; Teupser D; Vogeser M; Zander J
Crit Care; 2014 Jul; 18(4):R148. PubMed ID: 25011656
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics and elimination efficiency of linezolid during dialysis.
Hiraki Y; Tsuji Y; Misumi N; Hiraike M; Matsumoto K; Morita K; Kamimura H; Karube Y
Ren Fail; 2013; 35(3):418-20. PubMed ID: 23356475
[TBL] [Abstract][Full Text] [Related]
26. Linezolid clearance during continuous venovenous hemodiafiltration: a case report.
Kraft MD; Pasko DA; DePestel DD; Ellis JJ; Peloquin CA; Mueller BA
Pharmacotherapy; 2003 Aug; 23(8):1071-5. PubMed ID: 12921253
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of linezolid in subjects with renal dysfunction.
Brier ME; Stalker DJ; Aronoff GR; Batts DH; Ryan KK; O'Grady M; Hopkins NK; Jungbluth GL
Antimicrob Agents Chemother; 2003 Sep; 47(9):2775-80. PubMed ID: 12936973
[TBL] [Abstract][Full Text] [Related]
28. Alveolar diffusion and pharmacokinetics of linezolid administered in continuous infusion to critically ill patients with ventilator-associated pneumonia.
Boselli E; Breilh D; Caillault-Sergent A; Djabarouti S; Guillaume C; Xuereb F; Bouvet L; Rimmelé T; Saux MC; Allaouchiche B
J Antimicrob Chemother; 2012 May; 67(5):1207-10. PubMed ID: 22351682
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia.
Boselli E; Breilh D; Rimmelé T; Djabarouti S; Toutain J; Chassard D; Saux MC; Allaouchiche B
Crit Care Med; 2005 Jul; 33(7):1529-33. PubMed ID: 16003058
[TBL] [Abstract][Full Text] [Related]
30. Analysis of thrombocytopenic effects and population pharmacokinetics of linezolid: a dosage strategy according to the trough concentration target and renal function in adult patients.
Matsumoto K; Shigemi A; Takeshita A; Watanabe E; Yokoyama Y; Ikawa K; Morikawa N; Takeda Y
Int J Antimicrob Agents; 2014 Sep; 44(3):242-7. PubMed ID: 25108880
[TBL] [Abstract][Full Text] [Related]
31. Linezolid extracorporeal removal during haemodialysis with high cut-off membrane in critically ill patients.
Villa G; Cassetta MI; Tofani L; Valente S; Chelazzi C; Falsini S; De Gaudio AR; Novelli A; Ronco C; Adembri C
Int J Antimicrob Agents; 2015 Oct; 46(4):465-8. PubMed ID: 26315198
[TBL] [Abstract][Full Text] [Related]
32. Penetration of linezolid into sternal bone of patients undergoing cardiopulmonary bypass surgery.
Metallidis S; Nikolaidis J; Lazaraki G; Koumentaki E; Gogou V; Topsis D; Nikolaidis P; Charokopos N; Theodoridis G
Int J Antimicrob Agents; 2007 Jun; 29(6):742-4. PubMed ID: 17374477
[No Abstract] [Full Text] [Related]
33. Linezolid dosage in pediatric patients based on pharmacokinetics and pharmacodynamics.
Matsumoto K; Shigemi A; Takeshita A; Watanabe E; Yokoyama Y; Ikawa K; Morikawa N; Takeda Y
J Infect Chemother; 2015 Jan; 21(1):70-3. PubMed ID: 25305808
[TBL] [Abstract][Full Text] [Related]
34. Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction.
Matsumoto K; Takeshita A; Ikawa K; Shigemi A; Yaji K; Shimodozono Y; Morikawa N; Takeda Y; Yamada K
Int J Antimicrob Agents; 2010 Aug; 36(2):179-81. PubMed ID: 20392606
[TBL] [Abstract][Full Text] [Related]
35. Influence of linezolid clearance on the induction of thrombocytopenia and reduction of hemoglobin.
Hiraki Y; Tsuji Y; Matsumoto K; Morita K; Kamimura H; Karube Y
Am J Med Sci; 2011 Dec; 342(6):456-60. PubMed ID: 21681075
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics and antimicrobial dosing adjustment in critically ill patients during continuous renal replacement therapy.
Kuang D; Verbine A; Ronco C
Clin Nephrol; 2007 May; 67(5):267-84. PubMed ID: 17542336
[TBL] [Abstract][Full Text] [Related]
37. Linezolid pharmacokinetics in pediatric patients: an overview.
Jungbluth GL; Welshman IR; Hopkins NK
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S153-7. PubMed ID: 14520140
[TBL] [Abstract][Full Text] [Related]
38. Plasma exposure of free linezolid and its ratio to minimum inhibitory concentration varies in critically ill patients.
Yagi T; Naito T; Doi M; Nagura O; Yamada T; Maekawa M; Sato S; Kawakami J
Int J Antimicrob Agents; 2013 Oct; 42(4):329-34. PubMed ID: 23988716
[TBL] [Abstract][Full Text] [Related]
39. Linezolid in the central nervous system: comparison between cerebrospinal fluid and plasma pharmacokinetics.
Viaggi B; Paolo AD; Danesi R; Polillo M; Ciofi L; Del Tacca M; Malacarne P
Scand J Infect Dis; 2011 Sep; 43(9):721-7. PubMed ID: 21585240
[TBL] [Abstract][Full Text] [Related]
40. Clearance of linezolid via continuous venovenous hemodiafiltration.
Mauro LS; Peloquin CA; Schmude K; Assaly R; Malhotra D
Am J Kidney Dis; 2006 Jun; 47(6):e83-6. PubMed ID: 16731287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
